These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28855536)

  • 1. Transforming Growth Factor Beta is regulated by a Glucocorticoid-Dependent Mechanism in Denervation Mouse Bone.
    Li Y; Jie L; Tian AY; Zhong S; Tian MY; Zhong Y; Wang Y; Li H; Li J; Sun X; Du H
    Sci Rep; 2017 Aug; 7(1):9925. PubMed ID: 28855536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β prevents the denervation-induced reduction of bone formation and promotes the bone regeneration through inhibiting ubiquitin-proteasome pathway.
    Yu Z; Li Y; Wang Y; Chen Y; Wu M; Wang Z; Song M; Lu F; Lu X; Dong Z
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015371
    [No Abstract]   [Full Text] [Related]  

  • 4. Transforming growth factor-beta1 gene polymorphisms and bone turnover, bone mineral density and fracture risk in southern Chinese women.
    Lau HH; Ho AY; Luk KD; Kung AW
    Calcif Tissue Int; 2004 Jun; 74(6):516-21. PubMed ID: 15354859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the combined Herba Epimedii and Fructus Ligustri Lucidi on bone turnover and TGF-β1/Smads pathway in GIOP rats.
    Yang Y; Nian H; Tang X; Wang X; Liu R
    J Ethnopharmacol; 2017 Apr; 201():91-99. PubMed ID: 28254481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β Stimulates Endochondral Differentiation after Denervation.
    Li Y; Tian AY; Ophene J; Tian MY; Yao Z; Chen S; Li H; Sun X; Du H
    Int J Med Sci; 2017; 14(4):382-389. PubMed ID: 28553171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
    Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME
    Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression of TGF-beta, TGF-beta receptor, and extracellular matrix proteins during membranous bone healing in rats.
    Steinbrech DS; Mehrara BJ; Rowe NM; Dudziak ME; Luchs JS; Saadeh PB; Gittes GK; Longaker MT
    Plast Reconstr Surg; 2000 May; 105(6):2028-38. PubMed ID: 10839400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
    Jacobs JW; de Nijs RN; Lems WF; Geusens PP; Laan RF; Huisman AM; Algra A; Buskens E; Hofbauer LC; Oostveen AC; Bruyn GA; Dijkmans BA; Bijlsma JW
    J Rheumatol; 2007 May; 34(5):1051-7. PubMed ID: 17407214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids modulate TGF-beta production by human fetal lung fibroblasts.
    Wen FQ; Kohyama T; Sköld CM; Zhu YK; Liu X; Romberger DJ; Stoner J; Rennard SI
    Inflammation; 2003 Feb; 27(1):9-19. PubMed ID: 12772773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salidroside alleviates dexamethasone-induced inhibition of bone formation via transforming growth factor-beta/Smad2/3 signaling pathway.
    Xie B; Zhou H; Liu H; Liao S; Zhou C; Xu D
    Phytother Res; 2023 May; 37(5):1938-1950. PubMed ID: 36567454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of TGF-β in a mouse model of high turnover renal osteodystrophy.
    Liu S; Song W; Boulanger JH; Tang W; Sabbagh Y; Kelley B; Gotschall R; Ryan S; Phillips L; Malley K; Cao X; Xia TH; Zhen G; Cao X; Ling H; Dechow PC; Bellido TM; Ledbetter SR; Schiavi SC
    J Bone Miner Res; 2014; 29(5):1141-57. PubMed ID: 24166835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration of transforming growth factor beta in human bone tissue: relationship to age, menopause, bone turnover, and bone volume.
    Pfeilschifter J; Diel I; Scheppach B; Bretz A; Krempien R; Erdmann J; Schmid G; Reske N; Bismar H; Seck T; Krempien B; Ziegler R
    J Bone Miner Res; 1998 Apr; 13(4):716-30. PubMed ID: 9556072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol.
    Kassem M; Kveiborg M; Eriksen EF
    Eur J Clin Invest; 2000 May; 30(5):429-37. PubMed ID: 10809903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone formation zones in heterotopic ossifications: histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3.
    Toom A; Arend A; Gunnarsson D; Ulfsparre R; Suutre S; Haviko T; Selstam G
    Calcif Tissue Int; 2007 Apr; 80(4):259-67. PubMed ID: 17401695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene.
    Geiser AG; Zeng QQ; Sato M; Helvering LM; Hirano T; Turner CH
    Bone; 1998 Aug; 23(2):87-93. PubMed ID: 9701466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factors beta1, beta2, and beta3 and their receptors are differentially regulated during normal and impaired wound healing.
    Frank S; Madlener M; Werner S
    J Biol Chem; 1996 Apr; 271(17):10188-93. PubMed ID: 8626581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass.
    Filvaroff E; Erlebacher A; Ye J; Gitelman SE; Lotz J; Heillman M; Derynck R
    Development; 1999 Oct; 126(19):4267-79. PubMed ID: 10477295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.